TELA Bio (TELA) Accumulated Depreciation & Amortization (2018 - 2025)

TELA Bio has reported Accumulated Depreciation & Amortization for 8 years, with the latest figure at $3.5 million in Q4 2025.

• For the quarter ending Q4 2025, Accumulated Depreciation & Amortization fell 25.15% year-over-year to $3.5 million; the trailing twelve-month figure through Dec 2025 stood at $3.5 million (down 25.15% YoY), and the FY2025 full-year result was $3.5 million, down 25.15% from the prior year.
• Accumulated Depreciation & Amortization for Q4 2025 stood at $3.5 million, down from $4.7 million in the prior quarter.
• The five-year high for Accumulated Depreciation & Amortization was $4.7 million in Q4 2024, with the low at $3.5 million in Q4 2025.
• Average Accumulated Depreciation & Amortization over 5 years is $4.1 million, with a median of $4.1 million recorded in 2022.
• Year-over-year, Accumulated Depreciation & Amortization grew 10.19% in 2022 and decreased 25.15% in 2025.
• Tracing TELA's Accumulated Depreciation & Amortization over 5 years: stood at $3.8 million in 2021, then gained by 10.19% to $4.1 million in 2022, then increased by 4.71% to $4.3 million in 2023, then advanced by 7.5% to $4.7 million in 2024, then declined by 25.15% to $3.5 million in 2025.
• The last three Accumulated Depreciation & Amortization figures came in at $3.5 million (Q4 2025), $4.7 million (Q4 2024), and $4.3 million (Q4 2023), per Business Quant data.

Peer Comparison